Type 2 diabetes management (Management of type 2 diabetes mellitus in adults)

What is type 2 diabetes management?

Type 2 diabetes is a long-term condition where the body cannot use insulin properly, and over time may not make enough of it. This causes glucose (sugar) to build up in the blood. It is different from type 1 diabetes and is linked to factors such as family history, age, ethnicity and being above a healthy weight, though it is not anyone's fault.

Managing type 2 diabetes usually combines healthy eating, physical activity, weight management and, for many people, medicines. Treatment is increasingly chosen not just to lower glucose but to protect the heart and kidneys, especially in people at higher risk. Some people can put their type 2 diabetes into remission through significant weight loss, particularly early on, though this is not possible for everyone and can change over time.

Management aims to keep glucose, blood pressure and cholesterol in healthy ranges and to prevent complications affecting the eyes, kidneys, nerves, feet and blood vessels. It works best as a long-term partnership with your healthcare team rather than a one-off fix.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

Common approaches in type 2 diabetes

Treatment is personalised and often changes over time. Your clinician will explain why a particular option suits you.

Preparing for your treatment

• Bring a list of all your medicines, including over-the-counter and herbal ones, and any allergies.
• Bring recent home glucose readings if you check them, and note any patterns or symptoms.
• Note questions about diet, weight, activity, medicines or remission.
• Bring details of your blood pressure readings if you monitor at home.
• Ask about a structured education course if you have not done one.
• Think about your goals, such as weight, energy, or reducing medicines, to discuss with your team.
• Mention any problems with current medicines, such as tummy upset or hypos.
• If you take an SGLT2 inhibitor ('-gliflozin' medicine) and have an operation, procedure or period of fasting planned, ask whether to pause it beforehand and how to manage sick days.
• If you take a GLP-1 or combined GLP-1/GIP medicine (such as semaglutide, liraglutide, dulaglutide or tirzepatide), including any bought privately, tell the team well before any general anaesthetic or deep sedation. These medicines can slow the stomach and leave food behind even after normal fasting, so the anaesthetist needs to know. Do not stop it on your own; the team will decide with you what is right.

What happens

Care usually starts with a discussion about your glucose levels, your overall health and your goals. You will get advice on eating, activity and weight, and support to make changes that fit your life. Many people are also offered medicines. Which ones you start with now depend on your other health conditions, your kidney function and how old you were when diabetes began, rather than a single fixed order. Under current NICE guidance in England, many people are offered a slow-release (modified-release) form of metformin together with a medicine called an SGLT2 inhibitor from the start. If you already have heart disease caused by furred-up arteries, a weekly injection called semaglutide may be added as well. If you developed diabetes at a younger age, or your kidney function is reduced, your team follows a specific tailored pathway for that situation, and if metformin does not suit you they will use an alternative combination. NHS services in Wales, Scotland and Northern Ireland follow their own national and local diabetes pathways, so the exact medicines and their availability can differ. Treatment is always tailored to you, including any other conditions, the chance of pregnancy, frailty and how your kidneys are working.

At regular reviews, your team checks your HbA1c (a measure of average glucose over about 3 months) and reviews your medicines. They also carry out or arrange checks of your eyes (retinal screening), kidneys (a urine and blood test), feet, blood pressure and cholesterol, because protecting these is a key part of diabetes care.

Treatment is adjusted over time as your needs change. Your team will explain the reasons for any changes and involve you in decisions, including how to balance the benefits of tighter control against side effects such as hypos with certain medicines.

Is this treatment right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

The biggest long-term risk is damage to blood vessels and nerves from glucose, blood pressure and cholesterol that stay too high over years. Some medicines can cause hypos or need pausing during illness. Ask your clinician which of your medicines can cause hypos, what to do on sick days, and how your heart and kidney risk is being managed.

Published figures to discuss

The risk of complications in type 2 diabetes varies widely with glucose control, blood pressure, cholesterol, smoking, weight, how long someone has had diabetes and other factors. Reliable single percentages are hard to quote and can be misleading, so this guide uses cautious, qualitative wording and focuses on risk reduction and early detection rather than fixed numbers.

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

Type 2 diabetes is a long-term condition rather than something you recover from in the usual sense. 'Afterwards' here means how your glucose, weight and wellbeing respond to lifestyle changes and medicines over weeks and months.

• Glucose and weight improving gradually rather than overnight.
• Some medicine side effects, such as mild tummy upset, that often settle with time.
• Treatment changing over the years as your needs change.
• Days when managing diabetes feels like hard work - this is common and worth raising with your team.

Aftercare

• Take medicines as prescribed and tell your team about any side effects rather than just stopping them.
• Follow your eating and activity plan as far as you can, and ask for support if you are struggling.
• If you check glucose at home, do so as advised and bring readings to reviews.
• Know which medicines to pause during illness (sick-day rules) and when to seek advice. If you take an SGLT2 inhibitor ('-gliflozin' medicine), follow your written sick-day and operation/fasting plan and do not stop or permanently change it on your own without your team's advice.
• Look after your feet daily and report any cuts, blisters, numbness or colour changes.
• Attend annual eye, kidney and foot checks and keep blood pressure and cholesterol reviewed.
• Ask about remission, weight support or new treatments if your circumstances change.

• Up-to-date medicines list ready
• Home glucose or blood pressure readings, if taken
• Questions about diet, weight or remission noted
• Sick-day rules for relevant medicines understood
• Annual eye, kidney and foot checks booked
• Goals and any side effects ready to discuss

⚠ Get urgent help if…

• Very high glucose with extreme thirst, drowsiness, confusion or breathlessness - seek urgent help.
• Hypo symptoms (shaking, sweating, confusion) if you take insulin or sulfonylureas, especially if they do not improve with sugar.
• Vomiting or illness that stops you eating or keeping fluids down, particularly if taking medicines that need pausing.
• A foot wound, ulcer, spreading redness or sudden numbness or colour change in a foot.
• Sudden changes in vision.
• Chest pain, severe breathlessness or stroke symptoms - call emergency services.
• Signs of a urine or genital infection that is not settling.
• If you take an SGLT2 inhibitor ('-gliflozin' medicine), signs of diabetic ketoacidosis even when your glucose is not very high: feeling sick or vomiting, tummy pain, unusual tiredness, deep or fast breathing, confusion, or a sweet or metallic taste or smell on your breath - seek urgent medical assessment.
• If you take a GLP-1 or combined GLP-1/GIP medicine (such as semaglutide, liraglutide, dulaglutide or tirzepatide), severe, persistent tummy pain - often spreading through to your back, with feeling sick or vomiting - can be inflammation of the pancreas and needs urgent assessment. The medicine should be stopped if this is suspected and not restarted if it is confirmed, on your team's advice.
• With semaglutide (brands include Ozempic, Wegovy and Rybelsus), a very rare eye problem: sudden painless partial or complete loss of vision, or rapidly worsening eyesight, needs immediate assessment at an eye casualty unit or A&E.

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

Well-managed type 2 diabetes means keeping glucose, blood pressure and cholesterol in healthy ranges and reducing the risk of complications. HbA1c shows average glucose over weeks to months, and complication checks track longer-term health. For some people, significant weight loss leads to remission, where glucose returns to a normal range without diabetes medicines.

No result guarantees freedom from complications, and remission can be lost if weight is regained or the condition progresses. The aim is steady, sustainable control and risk reduction, agreed with your team, rather than a single target hit once.

Type 2 diabetes is usually a long-term condition, and the body's ability to control glucose often changes over the years, so treatment may need to step up even if you are doing everything well. Remission, where achieved, needs ongoing healthy habits to maintain and should still be followed up, because diabetes can return. Regular review keeps your plan matched to your current health.

Related tests, treatments or support

Type 2 diabetes care is usually combined with managing blood pressure and cholesterol and assessing overall heart risk, because these together drive complications. Weight management and, for some people, treatment for related conditions such as sleep apnoea or fatty liver may also be part of the picture. Your team will join these up.

Follow-up & long-term care

You should have a structured review at least once a year, with extra contact when starting or changing medicines, or if you are unwell. Eye (retinal) screening, kidney testing, foot checks and blood pressure and cholesterol monitoring are arranged on a regular schedule, and there should be a clear route to contact your team between visits.

• Take prescribed medicines and review them regularly with your team.
• Keep up healthy eating, activity and weight management with support.
• Attend annual eye (retinal) screening to protect your sight.
• Have kidney function and urine albumin checked regularly.
• Keep up foot checks and report any wounds or numbness early.
• Review blood pressure, cholesterol and overall heart risk.

Repeat, follow-on and what comes next

• Treatment is commonly stepped up over the years as glucose control changes.
• Medicines are often switched or combined to balance glucose control, side effects and heart and kidney protection.
• Remission, where achieved, may be lost if weight is regained or the condition progresses.
• Targets are individualised and may be relaxed in older or frail people to avoid hypos.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

• A clear, personalised plan covering glucose, blood pressure, cholesterol and weight.
• Sick-day rules for medicines that should be paused during illness.
• Regular HbA1c checks and timely adjustment of treatment.
• Scheduled eye, kidney and foot screening and management of heart risk.
• Access to lifestyle, weight and education support and a clear contact route between visits.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

• Whether care is led by a GP, a specialist team or a consultant, and how often you are seen.
• Length and frequency of appointments and any dietitian or education input.
• Medicines prescribed, including newer heart- and kidney-protective treatments.
• Any glucose monitoring equipment if recommended.
• Complication screening such as retinal photography, kidney tests and foot checks.
• Weight management programmes or remission support.
• Out-of-hours access and urgent advice arrangements in private care.

• The clinician or clinic fee and what each review includes.
• Whether medicines are included or charged separately.
• Which complication checks (eyes, kidneys, feet) are covered and how often.
• Access to a diabetes nurse, dietitian or education programme.
• Any weight management or remission support included.
• Out-of-hours and urgent advice arrangements.
• What happens, and what it costs, if you become unwell or need extra reviews.

On the NHS? Type 2 diabetes is routinely managed on the NHS, including medicines, education and complication checks; private care is mainly used for faster access, second opinions or additional support.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Consent traps and marketing red flags

These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.

Choosing a specialist safely

• Check the specialist is on the GMC Specialist Register for this area.
• Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
• You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
• Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
• You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Take this to your consultation. A good specialist will welcome every one of these.

• What should my HbA1c and blood pressure targets be, and why?
• Which of my medicines can cause hypos or need pausing when I am ill?
• Could I aim for remission, and what would that involve?
• Are any of my medicines also protecting my heart and kidneys?
• How often will my eyes, kidneys and feet be checked?
• What lifestyle or weight support is available to me?
• Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
• Will you be the specialist who carries out my treatment, and who looks after me afterwards?
• What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
• What does a realistic result look like — and what can this treatment not achieve?
• What are my options, including waiting, doing nothing for now, or choosing a different approach?
• Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
• What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Find a verified specialist for type 2 diabetes management

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: NHS - Type 2 diabetes NICE NG28 - Type 2 diabetes in adults: management NHS - Type 2 diabetes: health problems (complications) NICE - Type 2 diabetes prevention and care overview MHRA - SGLT2 inhibitors: diabetic ketoacidosis risk MHRA - GLP-1/GIP agonists: acute pancreatitis warnings MHRA - Semaglutide (Wegovy, Ozempic, Rybelsus): NAION risk MHRA - GLP-1/GIP agonists: aspiration risk under anaesthesia/sedation NICE NG28 - Type 2 diabetes: initial medicines

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.